Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Toxins (Basel) ; 15(1)2023 01 12.
Article in English | MEDLINE | ID: mdl-36668887

ABSTRACT

Here, we report the first evidence concerning the modulation of insect immune system activity after applying Solanum nigrum fruit extract (EXT). We focused on two main issues: (1) is EXT cytotoxic for Tenebrio molitor haemocytes? and (2) how EXT affects the basic immune mechanisms of T. molitor. The results indicate cytotoxic action of 0.01 and 0.1% EXT on beetle haemocytes. Both the injection of EXT and incubating haemocytes with the EXT solution on microscopic slides significantly increased the number of apoptotic cells. However, 24 h after injection of 0.1% EXT cytotoxic effect of the tested extract probably was masked by the increased number of circulating haemocytes. Application of 0.01 and 0.1% EXT led to impairment of the activity of basic immune mechanisms such as phenoloxidase activity and the lysozyme-like antimicrobial activity of T. molitor haemolymph. Moreover, the EXT elicited significant changes in the expression level of selected immune genes. However, some of the immunomodulatory effects of EXT were different in beetles with and without an activated immune system. The obtained results are an essential step toward a complete understanding of the EXT mode of action on the T. molitor physiology and its potential usage in pest control.


Subject(s)
Coleoptera , Solanum nigrum , Tenebrio , Animals , Fruit , Immune System , Plant Extracts/pharmacology
2.
Syst Biol Reprod Med ; 67(1): 50-63, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33094655

ABSTRACT

The action of myo-inositol (MI), belonging to the inositol family, has been shown to improve sperm quality. To further elucidate the efficacy of this substance in male fertility, we investigated in vivo the effects of a nutraceuticals mix, containing mainly myo-inositol (MI) and in vitro the action of the MI on human male gamete performance. Sperm samples were evaluated from 51 men: 21 healthy normozoospermic and 30 oligoasthenoteratozoospermic (OAT). In the latter group, 15 patients were orally treated with the nutraceutical mix and in the remaining 15 patients only MI was used directly on their ejaculated sperm. Comparing the pathologic samples with respect to normal samples we observed that motility, viability, Bcl-2 phosphorylation, and cholesterol efflux increased after in vitro and in vivo treatments. Glucose-6-phosphate dehydrogenase activity as well as triglycerides level and lipase activity highlighted an enhancement of energy expenditure upon the treatment. Uncapacitated sperm is characterized by an anabolic metabolism, to generate an energy reservoir which will be spent during the capacitation, an energy-consuming process needed to acquire the competence for the fertilization. Intriguingly, our finding highlights that the treatment with these substances facilitated the switch from uncapacitated to capacitated sperm, promoting the acquisition of the male gamete fertilizing capacity. Our data suggested that these substances act both directly on sperm and on spermatogenesis, improving the performance of OAT sperm invitro and invivo. The positive effects of these treatments could be of great help for men and couples who have difficulty to conceive achild in anatural way and/or during medical-assisted reproduction.Abbreviations: 30 OAT-untreated patients; B: 15 OAT patients treated in vivo; Bovine serum albumin (BSA); C: 15 OAT patients treated in vitro; cholesterol oxidase-peroxidase (CHOD-POD); H: Normozoospermic samples; HM: sperm from normospermic patients treated in vitro with MI; MI: Myoinositol: IM: Immobile motility; NP: Non-progressive motility; OAT: Oligoasthenoteratozoospermic; PPP: Pentose Phosphate Pathway; PR: Progressive motility; WHO: World Health Organization.


Subject(s)
Dietary Supplements , Inositol/pharmacology , Oligospermia/drug therapy , Spermatozoa/drug effects , Spermatozoa/physiology , Adult , Cell Survival/drug effects , Cholesterol/metabolism , Ejaculation , Female , Glucose/metabolism , Humans , Lipid Metabolism , Longitudinal Studies , Male , Pentose Phosphate Pathway/drug effects , Phosphorylation , Prospective Studies , Proto-Oncogene Proteins c-bcl-2/metabolism , Sperm Capacitation/drug effects , Sperm Motility/drug effects , Spermatogenesis/drug effects , Spermatozoa/metabolism
3.
Br J Nutr ; 117(1): 170-175, 2017 01.
Article in English | MEDLINE | ID: mdl-28098046

ABSTRACT

I prophylaxis is the most effective strategy to eradicate I deficiency disorders, but it has been shown to affect the thyroid disease pattern. In this study, we assessed the frequency of thyroid disorders in an adult population living in two areas of southern Italy after implementing I prophylaxis. To this aim, a cross-sectional, population-based study including 489 subjects from an I-deficient rural and an I-sufficient urban area of southern Italy was conducted. Thyroid ultrasound was performed on all participants, and urine and blood samples were collected from each subject. The levels of thyroid-stimulating hormone (TSH), thyroglobulin (TgAb) and thyroperoxidase antibodies (TPOAb), urinary I excretion (UIE), and thyroid volume and echogenicity were evaluated. We found that the median UIE was higher in the urban than in the rural area (P=0·004), whereas the prevalence of subjects affected by goitre was higher in the rural compared with the urban area (P=0·003). Positive TgAb rather than TPOAb were more frequent in subjects from the urban area compared with the rural area (P=0·009). The hypoechoic pattern at thyroid ultrasound (HT-US) was similar between the two areas, but TgAb were significantly higher (P=0·01) in HT-US subjects from the urban area. The frequency of elevated TSH did not differ between the two screened populations, and no changes were found for TgAb positivity in subjects with high TSH in the urban compared with the rural area. Our findings support that the small risks of I supplementation are far outweighed by the substantial benefits of correcting I deficiency, although continued monitoring of populations is necessary.


Subject(s)
Iodine/administration & dosage , Iodine/deficiency , Thyroid Diseases/epidemiology , Thyroid Diseases/prevention & control , Adult , Cross-Sectional Studies , Female , Humans , Italy , Male , Middle Aged
4.
Appl Immunohistochem Mol Morphol ; 23(5): 374-81, 2015.
Article in English | MEDLINE | ID: mdl-24992177

ABSTRACT

Varicocele, an abnormal tortuosity and dilation of veins of the pampiniform plexus, is the most common identifiable and correctable cause of male infertility. It is now becoming apparent that signaling through vitamin A metabolites, such as all-trans retinoic acid (ATRA), is indispensable for spermatogenesis and disruption of retinoic acid receptor-α (RARα) function may result in male sterility and aberrant spermatogenesis. Herein, we investigated by Western blot and immunogold electron microscopy the expression profiles and subcellular localization of RARα in healthy and varicocele human sperm; in addition, we analyzed the effects of ATRA on cholesterol efflux and sperm survival utilizing enzymatic colorimetric CHOD-PAP method and Eosin Y technique, respectively. In varicocele samples, a strong reduction of RARα expression was observed. Immunogold labeling evidenced cellular location of RARα also confirming its reduced expression in "varicocele" samples. Sperm responsiveness to ATRA treatment was reduced in varicocele sperm. Our study showed that RARα is expressed in human sperm probably with a dual role in promoting both cholesterol efflux and survival. RARα might be involved in the pathogenesis of varicocele as its expression is reduced in pathologic samples. Thus, ATRA administration in procedures for artificial insemination or dietary vitamin A supplementation might represent a promising therapeutic approach for the management of male infertility.


Subject(s)
Gene Expression , Receptors, Retinoic Acid/genetics , Spermatozoa/metabolism , Spermatozoa/ultrastructure , Varicocele/genetics , Biological Transport , Blotting, Western , Cells, Cultured , Cholesterol/metabolism , Eosine Yellowish-(YS) , Humans , Immunohistochemistry , Male , Microscopy, Electron , Receptors, Retinoic Acid/metabolism , Retinoic Acid Receptor alpha , Spermatic Cord/metabolism , Spermatic Cord/pathology , Spermatozoa/drug effects , Spermatozoa/pathology , Tretinoin/metabolism , Tretinoin/pharmacology , Varicocele/diagnosis , Varicocele/metabolism , Varicocele/pathology
5.
Mol Nutr Food Res ; 57(5): 840-53, 2013 May.
Article in English | MEDLINE | ID: mdl-23322423

ABSTRACT

SCOPE: Exposure of the breast to estrogens and other sex hormones is an important cancer risk factor and estrogen receptor downregulators are attracting significant clinical interest. Epigallocatechin gallate (EGCG), a polyphenolic compound found in green tea, has gained considerable attention for its antitumor properties. Here we aimed to investigate the molecular mechanisms through which EGCG regulates ER-α expression in ER+ PR+ breast cancer cells. MATERIAL AND METHODS: Western blotting analysis, real-time PCR, and transient transfections of deletion fragments of the ER-α gene promoter show that EGCG downregulates ER-α protein, mRNA, and gene promoter activity with a concomitant reduction of ER-α genomic and nongenomic signal. These events occur through p38(MAPK) /CK2 activation, causing the release from Hsp90 of progesterone receptor B (PR-B) and its consequent nuclear translocation as evidenced by immunofluorescence studies. EMSA, and ChIP assay reveal that, upon EGCG treatment, PR-B is recruited at the half-PRE site on ER-α promoter. This is concomitant with the formation of a corepressor complex containing NCoR and HDAC1 while RNA polymerase II is displaced. The events are crucially mediated by PR-B isoform, since they are abrogated with PR-B siRNA. CONCLUSION: Our data provide evidence for a mechanism by which EGCG downregulates ER-α and explains the inhibitory action of EGCG on the proliferation of ER+ PR+ cancer cells tested. We suggest that the EGCG/PR-B signaling should be further exploited for clinical approach.


Subject(s)
Breast Neoplasms/genetics , Catechin/analogs & derivatives , Down-Regulation , Estrogen Receptor alpha/genetics , Gene Expression Regulation, Neoplastic , Breast Neoplasms/pathology , Catechin/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Chromatin Immunoprecipitation , Estrogen Receptor alpha/metabolism , Female , HSP90 Heat-Shock Proteins/genetics , HSP90 Heat-Shock Proteins/metabolism , Histone Deacetylase 1/genetics , Histone Deacetylase 1/metabolism , Humans , Nuclear Receptor Co-Repressor 1/genetics , Nuclear Receptor Co-Repressor 1/metabolism , Promoter Regions, Genetic , RNA Polymerase II/genetics , RNA Polymerase II/metabolism , Real-Time Polymerase Chain Reaction , Signal Transduction , Tea/chemistry
6.
Mol Reprod Dev ; 80(2): 155-65, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23280600

ABSTRACT

Myricetin is a natural flavonoid, particularly enriched in red wines, whose occurrence is widespread among plants. Despite extensive research, the beneficial effects of Myricetin on human health are still controversial. Here, we tested the estrogen-like effect of the phytoestrogen Myricetin on human ejaculated sperm biology. To this aim, human normozoospermic samples were exposed to increasing concentrations (10 nM, 100 nM, and 1 µM) of Myricetin. Motility, viability, capacitation-associated biochemical changes (i.e., cholesterol efflux and tyrosine phosphorylation), acrosin activity, as well as glucose utilization and fatty-acid oxidation (i.e., glucose and lipid metabolism) were all significantly increased by low doses of Myricetin. Importantly, both estrogen receptors α and ß (ERs) and phosphatidylinositol-3-OH kinase (PI3K)/AKT signaling are activated in the presence of Myricetin since these were both abrogated by specific inhibitors of each pathway. Our results show how Myricetin, through ERs and PI3K/AKT signalings, potentiates sperm function. This effect is dose-dependent at low concentrations of Myricetin (up to 100 nM), whereas higher amounts do not seem to improve any further sperm motility, viability, or other tested features, and, in some cases, they reduced or even abrogated the efficacy exerted by lower doses. Further studies are needed to elucidate if high levels of Myricetin, which could be attained even with moderate wine consumption, could synergize with endogenous estrogens in the female reproductive tract, interfering with the physiological sperm fertilization process.


Subject(s)
Flavonoids/pharmacology , Phytoestrogens/pharmacology , Spermatozoa/physiology , Wine/analysis , Acrosin/metabolism , Analysis of Variance , Blotting, Western , Cell Survival/drug effects , Dose-Response Relationship, Drug , Fatty Acids/metabolism , Female , Flavonoids/analysis , Glucose/metabolism , Humans , Male , Phosphatidylinositol 3-Kinases/metabolism , Phytoestrogens/analysis , Sperm Capacitation/drug effects , Sperm Motility/drug effects , Spermatozoa/drug effects
7.
Mol Nutr Food Res ; 56(11): 1655-64, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22976781

ABSTRACT

SCOPE: Green tea and its major constituent epigallocatechin gallate (EGCG) have been extensively studied as potential treatment for a variety of diseases. We assessed the influence of EGCG on male fertilizing potential by analyzing different features of human sperm involved in capacitation process. METHODS AND RESULTS: Using human normozoospermic samples, we evaluated the effect of EGCG (2 µM, 20 µM, 60 µM) on sperm activities. Our results showed that lower doses of EGCG (from 2 to 20 µM) increased cholesterol efflux and tyrosine phosphorylation through the estrogen receptor (ER), since ICI 182,780, a specific ER antagonist, abrogated 20 µM EGCG effects. Besides, we evidenced that EGCG at similar concentrations, increased sperm motility, viability, and phosphorylation of proteins controlling cell survival such as Bcl2, Akt, and Src, via ER. Furthermore, we observed reduction of triglycerides content, induction of lipase, as well as the G6PDH activity. These results address to an increase in energy expenditure. On the contrary, treatment of 60 µM EGCG produced opposite effects that still appear after ICI cotreatment. CONCLUSION: These results provide a novel mechanism involving ERs through which low doses of EGCG exerted benefits to sperm physiology, also detected data evidence the adverse action of high EGCG concentrations probably related to its prooxidant and antiestrogenic potential.


Subject(s)
Catechin/analogs & derivatives , Spermatozoa/drug effects , Spermatozoa/metabolism , Catechin/pharmacology , Cell Survival/drug effects , Cholesterol/metabolism , Dose-Response Relationship, Drug , Estradiol/analogs & derivatives , Estradiol/pharmacology , Fulvestrant , Glucose/metabolism , Humans , Lipid Metabolism/drug effects , Male , Phosphorylation/drug effects , Proteins/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/metabolism , Sperm Motility/drug effects , Tea/chemistry , Triglycerides/metabolism , Tyrosine/metabolism , src-Family Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL